JAVMA news
All hydrocodone products now schedule II drugs
The Drug Enforcement Administration has scheduled all hydrocodone-containing products as schedule II drugs
JAVMA news
International joint statements address horse slaughter, rabies in dogs
The AVMA has adopted a joint statement on horse slaughter with the Canadian and Mexican veterinary associations and a joint statement on rabies in…
JAVMA news
More large-volume fluids become available
More large-volume polyionic fluids for parenteral administration in large animals have become available during an ongoing shortage.
JAVMA news
FDA conditionally approves drug for treating lymphoma in dogs
The Food and Drug Administration announced Jan. 3 that it has conditionally approved Tanovea-CA1, or rabacfosadine, as the first animal drug to treat…
JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
JAVMA news
FDA warns of eye injuries with use of canine ear medications
On Dec. 6, 2017, the Food and Drug Administration issued an alert about reports of eye injury and irritation in people and dogs following application…
JAVMA news
Cannabis research for veterinary patients advancing, cautiously
More than half the country has legalized marijuana use in one form or another.
JAVMA news
Relief practice not just a temporary gig
Relief practice predates the gig economy and is a mainstay in veterinary medicine. According to AVMA data, relief veterinarians make up the largest…